stearoyl alpha-lysolecithin

RN given refers to cpd without isomeric designation

Also Known As:

1-octadecyl-glycero-3-phosphocholine; 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine; 1-stearoyl-sn-glycero-3-phosphorylcholine; stearoyl L-alpha-lysolecithin; stearoyl alpha-lysolecithin, (+-)-isomer; stearoyl alpha-lysolecithin, (R)-isomer; stearoyllysophosphatidylcholine

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Membrane Lipids: 1591
  - Phospholipids: 11903
    - Glycerophosphates: 118
      - Phosphatidic Acids: 358
        Lysophospholipids: 554
        Lysophosphatidylcholines: 1350
        stearoyl alpha-lysolecithin: 2

Experts

1.	Cao, Shugeng: 1 article (12/2021)
2.	Choi, Hyukjae: 1 article (12/2021)
3.	Han, Ah-Reum: 1 article (12/2021)
4.	Jin, Chang Hyun: 1 article (12/2021)
5.	Kim, Bo-Ram: 1 article (12/2021)
6.	Kim, Geum Jin: 1 article (12/2021)
7.	Kim, Jin-Baek: 1 article (12/2021)
8.	Kim, Jung Min: 1 article (12/2021)
9.	Kim, Ye-Ram: 1 article (12/2021)
10.	Kwon, Soon-Jae: 1 article (12/2021)

Related Diseases

1.	Obesity 12/13/2021 - "Among PCs, 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (18:0 Lyso PC) was selected for further in vivo study of anti-obesity effect in a high-fat diet (HFD)-induced obese mouse model. "
2.	Neoplasms (Cancer) 01/01/2019 - "Here, temperature-sensitive plateletsomes (TSPs) composed of platelet (PLT) membrane, 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine were developed to adequately integrate chemotherapy with HIFU tumor ablation in vivo. "

Related Drugs and Biologics

1.	We 201
2.	colfosceril palmitate

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)